Crestline Management, LP Repare Therapeutics Inc. Transaction History
Crestline Management, LP
- $2.93 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$13.2 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.41 Million1.93% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.25 Million0.12% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.8 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.39 Million5.13% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $53.7M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...